Limitations, agreements, and source contact

Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia · Source last updated 2020-03-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

NDaver@mdanderson.org

organization

The University of Texas MD Anderson Cancer Center

phone

713-794-4392

title

Naval Daver, MD/Associate Professor

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice